Sleep Disorders Trial, Recruiting (NCT07156383)

Sleep Disorders Trial, Recruiting NCT07156383 Sponsor: University of Notre Dame Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT07156383 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who speak English
People who have been identified as having Insomnia Disorder based on standard diagnostic criteria (DSM-5), first through a screening process and then confirmed in a brief clinical interview

Who may not be able to join:

People who have sleep disorders other than Insomnia Disorder
People who have a hormone-related (endocrine) condition
People who work shifts or keep an extreme or highly irregular sleep schedule
People who are currently taking medication to help with sleep
People who are currently taking medication for a hormone-related (endocrine) condition
People who are currently taking any medication that may affect sleep or cortisol (a stress hormone) levels
People who use alcohol or substances heavily, or who have been diagnosed with an alcohol or substance use disorder
People who have a serious mental illness
People who have ongoing (chronic) medical conditions that could be made worse by restricting sleep
People who are pregnant or currently breastfeeding
People who are in the peri-menopausal stage, due to irregular periods and changing hormone levels at that life stage

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 574-631-5914

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07156383

Sponsor: University of Notre Dame

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 574-631-5914

More information: https://clinicaltrials.gov/study/NCT07156383

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who speak English
People who have been identified as having Insomnia Disorder based on standard diagnostic criteria (DSM-5), first through a screening process and then confirmed in a brief clinical interview

Who may not be able to join:

People who have sleep disorders other than Insomnia Disorder
People who have a hormone-related (endocrine) condition
People who work shifts or keep an extreme or highly irregular sleep schedule
People who are currently taking medication to help with sleep
People who are currently taking medication for a hormone-related (endocrine) condition
People who are currently taking any medication that may affect sleep or cortisol (a stress hormone) levels
People who use alcohol or substances heavily, or who have been diagnosed with an alcohol or substance use disorder
People who have a serious mental illness
People who have ongoing (chronic) medical conditions that could be made worse by restricting sleep
People who are pregnant or currently breastfeeding
People who are in the peri-menopausal stage, due to irregular periods and changing hormone levels at that life stage

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Notre Dame

Registry

ClinicalTrials.gov

Start date

29 September 2025

Est. completion

31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Insomnia Symptoms; Sleep Continuity Disturbance; Total Sleep Time; HPA-Axis Functioning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov